• Exchange: Oslo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

PhotoCure ASA

+ Add to Watchlist


27.800 NOK 2.100 8.17%

As of 10:25:00 ET on 12/23/2014.

Snapshot for PhotoCure ASA (PHO)

Open: 26.000 Day's Range: 26.000 - 27.800 Volume: 21,754
Previous Close: 25.700 52wk Range: 17.700 - 29.800 1-Yr Rtn: -7.95%

Stock Chart for PHO

No chart data available.
  • PHO:NO 27.800
  • 1D
  • 1M
  • 1Y
Interactive PHO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 2.8660
Relative P/E vs. OBX -
Earnings Per Share (NOK) (ttm) -0.1098
Est. EPS (NOK) (12/2014) 9.7000
Est. PEG Ratio -
Market Cap (M NOK) 594.73
Shares Outstanding (M) 21.39
30 Day Average Volume 30,653
Price/Book (mrq) 2.1378
Price/Sale (ttm) 4.5815
Dividend Indicated Gross Yield -%
Cash Dividend (NOK) 2.0000
Dividend Ex-Date 05/23/2013
5 Year Dividend Growth -
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHO

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for PHO

PhotoCure ASA develops and produces pharmaceutical photodynamic therapy products and devices. The Company utilizes light-activated drugs in the treatment of cancer and other medical conditions. PhotoCure markets Metvix, a cream for the treatment of skin disorders, and the Curelight lamp to be used with the cream. The Company works with international research centers.

Kjetil HestdalPresident/CEOErik DahlChief Financial Officer
Kathleen DeardorffChief Operating OfficerInger Ferner HeglundVP:Research & Development
More Company Profile & Key Executives for PHO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil